Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CART Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Temporarily pausedNCT03392064
What this trial is testing

Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC

Who this might be right for
Small Cell Lung Cancer
Amgen 6
Not applicableUnknownNCT02813837
What this trial is testing

Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignancies

Who this might be right for
Leukemia, B-CellLymphoma, B-Cell
Innovative Cellular Therapeutics Co., Ltd. 30
Testing effectiveness (Phase 2)UnknownNCT04884984
What this trial is testing

Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 20
Not applicableEnded earlyNCT03473496
What this trial is testing

CAR-T Cells Therapy in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma(MM)
Zhujiang Hospital 2
Early research (Phase 1)WithdrawnNCT07453446
What this trial is testing

Clinical Study of U29 Injection (CD30-CART) in Patients With CD30-Positive Relapsed/Refractory Lymphoma

Who this might be right for
Relapsed or Refractory Lymphoma
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Testing effectiveness (Phase 2)Looking for participantsNCT06947473
What this trial is testing

Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension
Beijing GoBroad Hospital 45
Very early researchEnded earlyNCT03060356
What this trial is testing

Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)

Who this might be right for
Malignant MelanomaBreast Cancer
University of Pennsylvania 77
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03356782
What this trial is testing

Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

Who this might be right for
SarcomaOsteoid SarcomaEwing Sarcoma
Shenzhen Geno-Immune Medical Institute 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05870917
What this trial is testing

VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia

Who this might be right for
Plasma Cell Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableEnded earlyNCT03473457
What this trial is testing

CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia(AML)
Zhujiang Hospital 2
Large-scale testing (Phase 3)UnknownNCT04287660
What this trial is testing

Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

Who this might be right for
Multiple Myeloma
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)WithdrawnNCT03098355
What this trial is testing

Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies

Who this might be right for
B-Cell LeukemiaB-Cell Lymphoma
Zhujiang Hospital
Very early researchUnknownNCT04617704
What this trial is testing

BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 15
Early research (Phase 1)Study completedNCT02159716
What this trial is testing

CART-meso in Mesothelin Expressing Cancers

Who this might be right for
Metastatic Pancreatic (Ductal) AdenocarcinomaEpithelial Ovarian CancerMalignant Epithelial Pleural Mesothelioma
University of Pennsylvania 19
Very early researchTemporarily pausedNCT06586658
What this trial is testing

Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells

Who this might be right for
Renal Cell Carcinoma
Shanghai Changzheng Hospital 9
Early research (Phase 1)Active Not RecruitingNCT06220201
What this trial is testing

Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Who this might be right for
Multiple SclerosisMyasthenia Gravis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 120
Very early researchNot Yet RecruitingNCT06097455
What this trial is testing

First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma

Who this might be right for
Refractory Non-Hodgkin LymphomaRelapsed Non-Hodgkin Lymphoma
Fundacion Clinic per a la Recerca Biomédica 40
Early research (Phase 1)Looking for participantsNCT06891742
What this trial is testing

Phase I Study of OriC902 in Treatment of Advanced HCC

Who this might be right for
HCC
Peking University 44
Testing effectiveness (Phase 2)Study completedNCT04539444
What this trial is testing

CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

Who this might be right for
Relapsed Non Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University 18
Testing effectiveness (Phase 2)Looking for participantsNCT07153068
What this trial is testing

SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies

Who this might be right for
T Lymphoblastic Leukemia/LymphomaAcute Myeloid Leukemia (AML)
Institute of Hematology & Blood Diseases Hospital, China 12
Next Page